Ironwood Pharmaceuticals Initiates Clinical Studies of Soluble Guanylate Cyclase Stimulators IW-1973 and IW-1701

Go back to Ironwood Pharmaceuticals Initiates Clinical Studies of Soluble Guanylate Cyclase Stimulators IW-1973 and IW-1701
IRONWOOD PHARMA-A (NASDAQ: IRWD) Delayed: 3.82 +0.28 (7.91%)
Previous Close $3.54    52 Week High $16.89 
Open $3.60    52 Week Low $7.35 
Day High $3.91    P/E N/A 
Day Low $3.57    EPS $-2.35 
Volume 2,521,049